酮色林治疗冠状动脉搭桥术后高血压的初步研究。
Ketanserin in the treatment of hypertension following coronary artery bypass surgery. A preliminary study.
作者信息
Diedericks B J, Roelofse J A, De Wet J I
出版信息
S Afr Med J. 1983 Oct 1;64(15):569-71.
PMID:6604947
Abstract
The possible role of 5-hydroxytryptamine (serotonin) in patients developing hypertension following coronary artery bypass surgery was investigated by intravenous administration of ketanserin, a specific 5-hydroxytryptamine-receptor antagonist. Our findings in the preliminary study indicate that 5-hydroxytryptamine might not play a role in the hypertension seen after coronary artery bypass surgery.
摘要
通过静脉注射特异性5-羟色胺受体拮抗剂酮色林，研究了5-羟色胺（血清素）在冠状动脉搭桥手术后发生高血压的患者中可能发挥的作用。我们初步研究的结果表明，5-羟色胺可能在冠状动脉搭桥手术后出现的高血压中不起作用。
Zotero 插件